This study will extend the investigations from study NCT01709981 on ClinicalTrials.gov, which remains double-blinded. However, while the main focus of study NCT01709981 is to evaluate markers of inflammation, the current study's main focus will be to evaluate peri-procedural myocardial infarction. Although recruitment for the current study will begin in 12/2015, the investigators will increase power by using data already collected in from the initial substudy NCT01709981.